Applied Clinical Trials
The FDA's new draft IVD Guidelines will need to be factored into how pharma clinical trial sponsors use IVDs in a clinical trial, study design, timeline for protocol development, IND submission, and study initiation.
Michele L. Buenafe
Advertisement
Articles by Michele L. Buenafe
Advertisement
Latest Updated Articles
- What Pharma Companies Need to Know About FDA's New Draft IVD Guidance
February 12th 2018
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
ACT Brief: Patient-Site Trust Barriers, Rare Disease Evidence Without Registry, and RWD Enrollment Accuracy
3
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
4
Trust, Technology, and the Patient-Site Relationship: Q&A with Andrea Valente, uMotif
5